To the best of our knowledge, this is the first study to demonstrate the usefulness of cystatin C as a diagnostic tool for multivessel disease and to suggest an optimal cutoff value in diabetes patients with normal renal function. The gene discussed is CST3; the disease is glycogen storage disease VI.